Progenity, Inc. is a biotechnology company. The Company is engaged in developing and commercializing molecular testing products and precision medicine. It applies multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics, to its molecular testing products and to the development of a suite of investigational ingestible devices and drug/device combinations designed to provide precise diagnostic sampling and drug delivery solutions. It offers integrated molecular tests and end-to-end support services that enable physicians to incorporate genetic testing into their office workflow and enables in ordering multiple tests from one source. The Company’s molecular tests are: Innatal Prenatal Screen, Preparent Carrier Test, Riscover Hereditary Cancer Test, Resura Prenatal Test for Monogenic Disease, and Anatomic and Molecular Pathology Tests. It is also developing an ingestible capsule platform designed to help diagnose and treat gastrointestinal (GI) disorders.